Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration
BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.
Projectdetails
Introduction
Reconstructive surgeries frequently require multiple, often complex, procedures at high social and economic costs. A shape-morphing implant that can be implanted using less invasive procedures and that then undergoes predesigned shape changes, leading to tissue expansion and allowing for complete degradation coupled with tissue regeneration, is a radically new treatment concept.
Project Goals
BIOMET4D aims to create a new generation of shape-shifting and load-bearing implants for dynamic tissue restoration and to introduce a revolutionary paradigm in how actuators can be implemented in biomedicine.
Technological Innovations
Science-towards-technology breakthroughs will be demonstrated with:
- New shape-morphing metamaterials
- 4D smart metallic actuators
- Advanced multi-domain optimization tools
- Proof-of-concept for two potential clinical applications
Technologically, this vision also goes beyond existing paradigms because of the step-by-step actuation mechanisms, enabled through the additive manufacturing of multi-material degradable metallic structures, that are targeted for an order of magnitude improvement compared to the state-of-the-art.
Long-term Vision
A futuristic long-term vision of this breakthrough technology is to dynamically regenerate entire tissues, such as a nose or an ear. Proof-of-concept will be demonstrated for:
- Craniosynostosis treatment
- Skin expansion
This long-term vision can only be achieved through an interdisciplinary approach and will likely have high social and economic impact as well as provide a new line of research for applications of smart metamaterials in medicine and engineering.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 4.039.541 |
Totale projectbegroting | € 4.039.541 |
Tijdlijn
Startdatum | 1-7-2022 |
Einddatum | 30-6-2026 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- FUNDACION IMDEA MATERIALESpenvoerder
- UNIVERSIDAD POLITECNICA DE MADRID
- SCHAEFFLER AEROSINT
- MEOTEC GMBH
- KLINIKUM DER UNIVERSITAET ZU KOELN
- UNIVERSITY OF GALWAY
- FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL GREGORIO MARANON
- UNIVERSITAETSKLINIKUM AACHEN
- AMAZEMET SP. Z O.O.
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Biointegrable soft actuators alimented by metabolic energyINTEGRATE aims to revolutionize implantable devices by using metabolic energy to power 3D-printed soft actuating materials and an energy-harvesting organ, enhancing autonomy and efficiency. | EIC Pathfinder | € 1.698.750 | 2022 | Details |
Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cordPiezo4Spine aims to create a groundbreaking 3D bioprinted mesh therapy for spinal cord injury that enhances neural repair through targeted mechanotransduction and gene therapy. | EIC Pathfinder | € 3.537.120 | 2023 | Details |
Bacteria Biofilm as bio-factory for tissue regenerationBIOACTION aims to transform biofilm-associated infections into a resource for tissue regeneration using functionalized bio-hydrogels and engineered liposomes, enhancing implant technology and health outcomes. | EIC Pathfinder | € 2.903.862 | 2023 | Details |
building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgansTHOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants. | EIC Pathfinder | € 3.994.150 | 2023 | Details |
Bioinspired cellular actuatorsBiCeps aims to create robust, muscle-inspired actuators using multi-material additive manufacturing to revolutionize mechanical motion and replace traditional motors across various sectors. | EIC Pathfinder | € 2.894.306 | 2025 | Details |
Biointegrable soft actuators alimented by metabolic energy
INTEGRATE aims to revolutionize implantable devices by using metabolic energy to power 3D-printed soft actuating materials and an energy-harvesting organ, enhancing autonomy and efficiency.
Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cord
Piezo4Spine aims to create a groundbreaking 3D bioprinted mesh therapy for spinal cord injury that enhances neural repair through targeted mechanotransduction and gene therapy.
Bacteria Biofilm as bio-factory for tissue regeneration
BIOACTION aims to transform biofilm-associated infections into a resource for tissue regeneration using functionalized bio-hydrogels and engineered liposomes, enhancing implant technology and health outcomes.
building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans
THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.
Bioinspired cellular actuators
BiCeps aims to create robust, muscle-inspired actuators using multi-material additive manufacturing to revolutionize mechanical motion and replace traditional motors across various sectors.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogelsmorphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth. | ERC Starting... | € 1.499.906 | 2023 | Details |
Dynamic control of Gaussian morphing structures via embedded fluidic networksThe project aims to create fully controllable shape-morphing materials using hybrid elastic plates with fluid-filled cavities, enabling precise programming of shape, mechanics, and deformation dynamics for biomedical applications. | ERC Starting... | € 1.499.601 | 2025 | Details |
Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable ScaffoldsMAD Control aims to develop a multifunctional platform for biodegradable cardiovascular scaffolds that enables precise, on-demand drug release through real-time imaging and magnetic actuation. | ERC Starting... | € 1.495.288 | 2024 | Details |
Morphing tubular structures for adaptive biomedical devicesStripe-oMorph aims to develop adaptable, bio-inspired morphing tubular structures for interventional medical devices, enhancing their compatibility with complex geometries and patient-specific needs. | ERC Proof of... | € 150.000 | 2022 | Details |
Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological TestingISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies. | ERC Proof of... | € 150.000 | 2023 | Details |
4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels
morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.
Dynamic control of Gaussian morphing structures via embedded fluidic networks
The project aims to create fully controllable shape-morphing materials using hybrid elastic plates with fluid-filled cavities, enabling precise programming of shape, mechanics, and deformation dynamics for biomedical applications.
Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable Scaffolds
MAD Control aims to develop a multifunctional platform for biodegradable cardiovascular scaffolds that enables precise, on-demand drug release through real-time imaging and magnetic actuation.
Morphing tubular structures for adaptive biomedical devices
Stripe-oMorph aims to develop adaptable, bio-inspired morphing tubular structures for interventional medical devices, enhancing their compatibility with complex geometries and patient-specific needs.
Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological Testing
ISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies.